Core Viewpoint - A class action lawsuit has been filed against Cepton, Inc. for allegedly making materially false and misleading statements regarding its business operations and compliance policies during the Class Period from July 29, 2024, to January 6, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Cepton received a credible third-party bid valuing the company at more than double the Koito Acquisition, which was not disclosed to shareholders [5]. - It is alleged that Cepton's Board of Directors failed to adequately explore this offer and did not disclose its terms when recommending the Koito Acquisition to shareholders [5]. - As a result, shareholders were deprived of the opportunity to meaningfully consider the acquisition, leading to materially false and misleading public statements by the defendants [5]. Group 2: Participation Information - Investors who purchased or sold Cepton, Inc. common stock during the Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6].

Core Points - Rosen Law Firm is reminding purchasers of KBR, Inc. securities from May 6, 2025, to June 19, 2025, about the November 18, 2025, lead plaintiff deadline in a securities class action lawsuit [1] - Investors who purchased KBR securities during the specified period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [3] Case Details - The lawsuit alleges that KBR's defendants made materially false and misleading statements regarding the company's partnership with HomeSafe and its ability to fulfill the Global Household Goods Contract, despite known concerns from the U.S. Department of Defense [5] - The lawsuit claims that these misleading statements resulted in damages to investors when the true details became public [5] Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements, including the largest securities class action settlement against a Chinese company at the time [4] - The firm has consistently ranked highly in securities class action settlements and has recovered hundreds of millions of dollars for investors, including over $438 million in 2019 alone [4]

Core Viewpoint - Rosen Law Firm is reminding purchasers of Tronox Holdings plc common stock of the upcoming lead plaintiff deadline for a class action lawsuit, indicating potential compensation for affected investors [1][2]. Group 1: Class Action Details - The class action pertains to investors who purchased Tronox common stock between February 12, 2025, and July 30, 2025, with a lead plaintiff deadline set for November 3, 2025 [1][2]. - Investors can join the class action without incurring out-of-pocket fees through a contingency fee arrangement [1]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a proven track record in securities class actions, highlighting its own success and recognition in this field [3]. - The firm has achieved significant settlements for investors, including over $438 million in 2019 alone, and has been consistently ranked among the top firms for securities class action settlements [3]. Group 3: Case Allegations - The lawsuit alleges that Tronox's management made misleading statements regarding the company's growth and performance in its pigment and zircon commercial division, which ultimately led to a failure in meeting revenue projections [4]. - It is claimed that while Tronox projected strong growth, the reality was a decline in sales and rising costs, resulting in damages for investors when the true state of the company was revealed [4].

Core Viewpoint - Rosen Law Firm is reminding investors who purchased LifeMD, Inc. securities between May 7, 2025, and August 5, 2025, about the upcoming lead plaintiff deadline for a securities class action lawsuit [1] Group 1: Class Action Details - Investors who purchased LifeMD securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by October 27, 2025 [3] - The lawsuit alleges that defendants made materially false and misleading statements regarding LifeMD's competitive position and financial guidance, particularly concerning customer acquisition costs [5] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting its own achievements in this area [4] - The firm has secured significant settlements for investors, including over $438 million in 2019, and has been consistently ranked among the top firms for securities class action settlements since 2013 [4]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Fluor Corporation securities between February 18, 2025, and July 31, 2025, about the upcoming lead plaintiff deadline on November 14, 2025, for a class action lawsuit [1] Group 1: Class Action Details - Investors who bought Fluor securities during the specified Class Period may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by the November 14, 2025 deadline [2] - The lawsuit alleges that Fluor made false and misleading statements regarding project costs and financial guidance, which negatively impacted its business and financial results [4] Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] - The firm has achieved significant settlements, including the largest securities class action settlement against a Chinese company at the time, and has consistently ranked highly in securities class action settlements [3] - In 2019, the firm secured over $438 million for investors, showcasing its capability in recovering funds for clients [3]

Core Points - Rosen Law Firm is reminding investors who purchased Fly-E Group, Inc. securities between July 15, 2025, and August 14, 2025, of the November 10, 2025, lead plaintiff deadline for a class action lawsuit [1][2] - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [1] - The lawsuit alleges that Fly-E provided misleading statements regarding the safety of its lithium battery, which negatively impacted its E-vehicle sales revenue [4] Group 1 - The class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm [2][5] - A lead plaintiff is required to act on behalf of other class members and must file a motion by November 10, 2025 [2] - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [3] Group 2 - The lawsuit claims that Fly-E's optimistic statements were contradicted by material adverse facts, leading to a decline in sales and increased operating expenses [4] - The firm has a history of significant recoveries for investors, including over $438 million in 2019 [3] - Rosen Law Firm has been recognized for its success in securities class action settlements, ranking in the top 4 since 2013 [3]

Core Viewpoint - Rosen Law Firm is reminding investors who purchased V.F. Corporation securities during the specified class period of the upcoming lead plaintiff deadline on November 12, 2025 [1] Group 1: Class Action Details - Investors who purchased V.F. Corporation securities between October 30, 2023, and May 20, 2025, may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2] - A class action lawsuit has already been filed, and interested parties can join by submitting a form or contacting the law firm [3][6] - The lawsuit alleges that V.F. Corporation's management provided misleading information regarding the company's turnaround plans, particularly concerning the Vans brand [5] Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may lack the necessary experience [4] - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [4] Group 3: Case Specifics - The lawsuit claims that V.F. Corporation's management concealed the need for significant reset actions to return the Vans brand to growth, which negatively impacted revenue growth [5]

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class action lawsuit on behalf of purchasers and acquirers of aTyr Pharma, Inc. (NASDAQ: ATYR) common stock between January 16, 2025 and September 12, 2025, both dates inclusive (the "Class Period†). aTyr is a clinical stage biotechnology company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is I. ...

Core Viewpoint - Rosen Law Firm is reminding investors who purchased Cytokinetics, Inc. common stock between December 27, 2023, and May 6, 2025, of the upcoming lead plaintiff deadline on November 17, 2025, for a class action lawsuit related to misleading statements about the company's drug approval process [1][5]. Group 1: Class Action Details - Investors who bought Cytokinetics common stock during the specified Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties can join by contacting Rosen Law Firm or through their website [3][6]. - The lawsuit alleges that Cytokinetics made false statements regarding the timeline for the New Drug Application (NDA) submission and approval for aficamten, which misled investors about the regulatory process [5]. Group 2: Rosen Law Firm's Credentials - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions, highlighting their own achievements in recovering hundreds of millions of dollars for investors [4]. - The firm has been recognized for its leadership in securities class action settlements, including being ranked No. 1 by ISS Securities Class Action Services in 2017 and securing over $438 million for investors in 2019 [4].

Core Viewpoint - Rosen Law Firm is investigating potential securities claims on behalf of shareholders of America's Car-Mart, Inc. due to allegations of materially misleading business information issued by the company [1]. Group 1: Investigation and Legal Action - Shareholders who purchased America's Car-Mart, Inc. securities may be entitled to compensation through a contingency fee arrangement, with no out-of-pocket costs [2]. - A class action is being prepared by Rosen Law Firm to seek recovery of investor losses [2]. Group 2: Recent Company Performance - On September 4, 2025, America's Car-Mart, Inc. reported a first-quarter loss of $0.69 per share, compared to a net loss of $0.15 per share in the same period the previous year [4]. - Following the release of these results, the stock of America's Car-Mart, Inc. fell by 18.2% on the same day [4]. Group 3: Rosen Law Firm's Credentials - Rosen Law Firm has a strong track record in securities class actions, having achieved the largest securities class action settlement against a Chinese company at the time [5]. - The firm has been ranked in the top 4 for securities class action settlements since 2013 and recovered hundreds of millions of dollars for investors, including over $438 million in 2019 [5].